TP53 and breast cancer: Taken together, our study identifies that BRD7 stabilizes p53 by regulating the phosphorylation of MDM2 via AKT pathway dependent on its bromodomain (BRD) to function as a tumor suppressor in breast cancer harboring wild-type p53.